Home

The Martinez Lab

The Martinez lab constitutes one of three labs in the Biorecognition group.

The Martinez lab studies the relationship between molecular structure and function to understand human health and disease. We use a combination of computational and experimental techniques, within the fields of biophysics, biochemistry and cellular biology. We aim to develop new therapeutic options for inborn errors of metabolism, in particular Phenylketonuria and neurotransmitter disorders (e.g. tyrosine hydroxylase deficiency).

Permanent staff:

Professor Aurora Martinez
Professor Knut Teigen
Ming Ying, chief engineer

News

Pluvia attracts interest from new governmental seed funding

Sarsia Seed recently announced their new seed funds in Bergen consisting of 300 million NOK. Initial investment can be in the biotechnology company Pluvia founded by Prof. Aurora Martinez according to Sarsia officials.

Biomedicine

New research sheds light on mechanisms behind serious brain disorder

Together with researchers from the University of Zurich, resarch groups at the University of Bergen have contributed to a better understanding of a rare, but serious, brain disorder.

Screening

NRC supports the NOR-Openscreen infrastructure initiative

The Biorecognition group at the Department of Biomedicine represents one of the four nodes in the new NOR-Openscreen infrastructure. The infrastructure will support the discovery of biologically active substances in all areas of the Life Sciences by providing transnational, open access to the most...

Bioinformatics

Bio3D-web: New online tools for protein structure analysis

Bio3D-web is a new online tool for the analyses of sequence, structure and conformational heterogeneity of protein families. The tool is developed by researcher Dr. Lars Skjærven, member of the the Biorecognition group, in collaboration with Prof. Barry J. Grant at the University of Michigan.

News

Aurora in the USC J-1 Newsletter

Auroras work at USC highlighted in the J1 Newsletter.